Suchbegriffe: MYASTHENIA, . Treffer: 14
Krenn, M; Sener, M; Rath, J; Zulehner, G; Keritam, O; Wagner, M; Laccone, F; Iglseder, S; Marte, S; Baumgartner, M; Eisenkölbl, A; Liechtenstein, C; Rudnik, S; Quasthoff, S; Grinzinger, S; Spenger, J; Wortmann, SB; Löscher, WN; Zimprich, F; Kellersmann, A; Rappold, M; Bernert, G; Freilinger, M; Cetin, H
The clinical and molecular landscape of congenital myasthenic syndromes in Austria: a nationwide study.
J NEUROL. 2022;
Doi: 10.1007/s00415-022-11440-0
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Neuhaus, O; Wiesmüller, KH; Hartung, HP; Wiendl, H
Prominent T-Cell Responses against the Acetylcholine Receptor ε Subunit in Myasthenia Gravis.
Neurol Res Int. 2019; 2019(4):1969068-1969068
Doi: 10.1155/2019/1969068
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Topakian, R; Zimprich, F; Iglseder, S; Embacher, N; Guger, M; Stieglbauer, K; Langenscheidt, D; Rath, J; Quasthoff, S; Simschitz, P; Wanschitz, J; Windisch, D; Müller, P; Oel, D; Schustereder, G; Einsiedler, S; Eggers, C; Löscher, W
High efficacy of rituximab for myasthenia gravis: a comprehensive nationwide study in Austria.
J Neurol. 2019; 266(3):699-706
Doi: 10.1007/s00415-019-09191-6
Web of Science
PubMed
FullText
FullText_MUG
Zimmermann, M; Rose, N; Lindner, JM; Kim, H; Gonçalves, AR; Callegari, I; Syedbasha, M; Kaufmann, L; Egli, A; Lindberg, RLP; Kappos, L; Traggiai, E; Sanderson, NSR; Derfuss, T
Antigen Extraction and B Cell Activation Enable Identification of Rare Membrane Antigen Specific Human B Cells.
Front Immunol. 2019; 10: 829-829.
Doi: 10.3389/fimmu.2019.00829
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Stieglbauer, K; Pichler, R; Topakian, R
10-year-outcomes after rituximab for myasthenia gravis: Efficacy, safety, costs of inhospital care, and impact on childbearing potential.
J Neurol Sci. 2017; 375(2): 241-244.
Doi: 10.1016/j.jns.2017.02.009
Web of Science
PubMed
FullText
FullText_MUG
Finsterer, J; Löscher, WN; Wanschitz, J; Quasthoff, S; Grisold, W
Secondary myopathy due to systemic diseases.
Acta Neurol Scand. 2016; 134(6):388-402
Doi: 10.1111/ane.12576
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Lindenmann, J; Fink-Neuboeck, N; Pichler, M; Anegg, U; Maier, A; Smolle, J; Smolle-Juettner, FM
Stage-based treatment for thymoma in due consideration of thymectomy: a single-center experience and comparison with the literature.
World J Surg Oncol. 2015; 13(2):303-303
Doi: 10.1186/s12957-015-0718-z
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Finsterer, J; Papić, L; Auer-Grumbach, M
Motor neuron, nerve, and neuromuscular junction disease.
Curr Opin Neurol. 2011; 24(5):469-474
Doi: 10.1097/WCO.0b013e32834a9448
Web of Science
PubMed
FullText
FullText_MUG
Grauer, O; Wolff, D; Bertz, H; Greinix, H; Kühl, JS; Lawitschka, A; Lee, SJ; Pavletic, SZ; Holler, E; Kleiter, I
Neurological manifestations of chronic graft-versus-host disease after allogeneic haematopoietic stem cell transplantation: report from the Consensus Conference on Clinical Practice in chronic graft-versus-host disease.
Brain. 2010; 133(10): 2852-2865.
Doi: 10.1093/brain/awq245
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Langmann, A; Lindner, S; Koch, M; Diez, J
Ocular myasthenia: a diagnostic and management challenge--a review
KLIN MONATSBL AUGENHEILK. 2004; 221(2): 77-86.
Doi: 10.1055/s-2004-812718
Web of Science
PubMed
FullText
FullText_MUG
Stangel, M; Hartung, HP; Marx, P; Gold, R
Intravenous immunoglobulin treatment of neurological autoimmune diseases.
J Neurol Sci. 1998; 153(2):203-214
Doi: 10.1016/S0022-510X(97)00292-X
Web of Science
PubMed
FullText
FullText_MUG
Marx, A; Wilisch, A; Schultz, A; Gattenlohner, S; Nenninger, R; MullerHermelink, HK
Pathogenesis of myasthenia gravis.
Virchows Arch. 1997; 430(5):355-364
Doi: 10.1007/s004280050044
Web of Science
PubMed
FullText
FullText_MUG
GATTENLOHNER, S; BRABLETZ, T; SCHULTZ, A; MARX, A; MULLERHERMELINK, HK; KIRCHNER, T
Cloning of a cDNA coding for the acetylcholine receptor alpha-subunit from a thymoma associated with myasthenia [correction of myastenia] gravis.
Thymus. 1994; 23(2):103-113
Web of Science
PubMed
MARX, A; SCHOMIG, D; SCHULTZ, A; GATTENLOHNER, S; JUNG, A; KIRCHNER, T; MELMS, A; MULLERHERMELINK, HK
Distribution of molecules mediating thymocyte-stroma-interactions in human thymus, thymitis and thymic epithelial tumors.
Thymus. 1994; 23(2):83-93
Web of Science
PubMed